Related Articles
Increased MIR31HG lncRNA expression increases gefitinib resistance in non-small cell lung cancer cell lines through the EGFR/PI3K/AKT signaling pathway
Characterization of distinct types of KRAS mutation and its impact on first‑line platinum‑based chemotherapy in Chinese patients with advanced non‑small cell lung cancer
Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler
GATA binding protein 2 overexpression is associated with poor prognosis in KRAS mutant colorectal cancer
Low‑dose trametinib and Bcl‑xL antagonist have a specific antitumor effect in KRAS‑mutated colorectal cancer cells